ResearcherChongqing Medical UniversityNo recent work listed

Yu Zeng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0970-9537; OpenAlex author ID A5001136929. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2019: 1 paper

Papers 1

An overactive neddylation pathway serves as a therapeutic target and MLN4924 enhances the anticancer activity of cisplatin in pancreatic cancer. Co-author DOI 10.3892/ol.2019.10596 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Li He · 1 shared paper, 2019 · strength 0.12
- Paper An overactive neddylation pathway serves as a therapeutic target and MLN4924 enhances the anticancer activity of cispla… DOI 10.3892/ol.2019.10596 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.